Clinical Immunotherapy of B-Cell Malignancy Using CD19-Targeted CAR T-Cells

Publisher： Bentham Science Publishers

E-ISSN： 1875-5631|14|1|35-43

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.14, Iss.1, 2014-02, pp. : 35-43

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

B Cells: Programmers of CD4 T Cell Responses

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 12, Iss. 3, 2012-06 ,pp. : 222-231

Bentham Science Publishers

Access to resources Recommend Favorite

Antigen-based T-cell-targeted immunotherapy: recent developments in autoimmunity and allergy

By Stemmer C.   Guichard G.  

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 7, 1998-07 ,pp. : 819-830

Informa Healthcare

Access to resources Recommend Favorite

Genetic Vaccination for the Immunotherapy of B-Cell Malignancies

By  

Current Gene Therapy, Vol. 2, Iss. 2, 2002-01 ,pp. : 235-242

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of B Cells in Multiple Sclerosis: Implications for B-Cell-Targeted Therapy

By  

Current Medicinal Chemistry, Vol. 17, Iss. 28, 2010-09 ,pp. : 3215-3222

Bentham Science Publishers

Access to resources Recommend Favorite

T Cell Targeted Allergen Derivatives for Improved Efficacy and Safety of Specific Immunotherapy for Allergic Disease

By  

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 2, Iss. 4, 2003-12 ,pp. : 351-365

Bentham Science Publishers

Access to resources Recommend Favorite